newsfilter
← Latest News
GlobeNewswire·

Pluristem CEO Issues Shareholder Update on Clinical Programs

HAIFA, Israel, July 21, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological products,...